TEKLA CAPITAL MANAGEMENT LLC
2 LIBERTY SQUARE, BOSTON, Massachusetts, 02109, (617) 772-8500
Report Date: 03/31/2013
Position Statistics:
| Total Positions | 65 |
| New Positions | 4 |
| Increased Positions | 11 |
| Decreased Positions | 16 |
| Positions with Activity | 27 |
| Sold Out Positions | 4 |
| Total Mkt Value (in $ millions) |
773 |
Sector Weighting
| Basic Materials | |
| Capital Goods | |
| Conglomerates | 3.36% |
| Consumer Cyclical | |
| Consumer/Non-Cyclical | |
| Energy | |
| Financial | 2.3% |
| Healthcare | 91.55% |
| Services | 0.55% |
| Technology | 2.23% |
| Transportation | |
| Utilities |
Institutional Holdings information is filed by major institutions on form 13-F with the Securities and Exchange Commission.
27 Activity Positions as of 03/31/2013
| Company | Class | Value of Shares ($1,000s) |
Change in Value ($1,000s) | Change (%) | Shares Held |
|---|---|---|---|---|---|
| REGENERON PHARMACEUTICALS | COM | 67,914 | -7,546 | (10) | 279,759 |
| CELGENE CORP | COM | 61,328 | -8,761 | (12.5) | 510,046 |
| PUMA BIOTECHNOLOGY INC | COM | 39,090 | -3,887 | (9.04) | 1,005,667 |
| ALEXION PHARMACEUTICALS INC | COM | 34,307 | 3,788 | 12.41 | 371,329 |
| ONYX PHARMACEUTICALS INC | COM | 20,820 | 4,374 | 26.60 | 234,456 |
| MYLAN INC | COM | 20,746 | -4,139 | (16.63) | 650,954 |
| QUESTCOR PHARMACEUTICALS INC | COM | 15,977 | -2,282 | (12.5) | 347,856 |
| WARNER CHILCOTT PLC IRELAND | SHS A | 15,464 | 3,892 | 33.63 | 782,797 |
| SHIRE PLC | SPONSORED ADR | 12,491 | -3,991 | (24.22) | 127,053 |
| NEUROCRINE BIOSCIENCES INC | COM | 11,989 | -6,841 | (36.33) | 943,987 |
| MEDIVATION INC | COM | 10,306 | -2,417 | (19) | 211,399 |
| AMGEN INC | COM | 9,654 | 8,638 | 850.24 | 95,109 |
| ALKERMES PLC | SHS | 9,357 | -3,119 | (25) | 312,827 |
| AMARIN CORP PLC | SPONS ADR NEW | 7,039 | 1,828 | 35.09 | 1,066,498 |
| FOREST LABS INC | COM | 6,090 | 6,090 | New | 146,500 |
| ALLERGAN INC | COM | 5,957 | -5,075 | (46) | 58,700 |
| ACCURAY INC | COM | 4,318 | 354 | 8.93 | 731,943 |
| EDWARDS LIFESCIENCES CORP | COM | 3,062 | -1,021 | (25) | 43,650 |
| SAGENT PHARMACEUTICALS INC | COM | 2,782 | 2,782 | New | 141,126 |
| COVANCE INC | COM | 2,761 | -8,282 | (75) | 35,000 |
Latest News Headlines
Exide Technologies Issues Statement on Vernon Facility 7:52PM ET - GlobeNewswire
Global Geophysical Services, Inc. to Present at the Global Hunter Securities 100 Energy Conference 7:50PM ET - GlobeNewswire
Repros Therapeutics Inc.(R) Announces Pricing of Public Offering of Common Stock 7:35PM ET - GlobeNewswire
Ebix and Affiliate of Goldman Sachs Agree to Terminate Merger Agreement 7:25PM ET - GlobeNewswire
Smithfield Bid for Canada's Maple Leaf Foods in March 7:15PM ET - Dow Jones Business News
View All